Fasken Martineau was retained by a number of global drug manufacturers in connection with provincial product listing agreements (i.e. reimbursement) for various products, including diabetes and oncology products. In particular, Fasken Martineau advised on the new legislation and complex government policies in Quebec. Fasken Martineau also drafted contractual agreements reflecting these parameters.